Psychedelics in the Treatment of Substance Use Disorders: What Clinicians Need to Know (Enduring Material)
Psychedelics in the Treatment of Substance Use Disorders: What Clinicians Need to Know (Enduring Material) is organized by Providers Clinical Support System (PCSS).
Release Date: 11/10/2023
Expiration Date: 06/01/2026.
Description:
Requirements for Successful Activity Completion
In order to successfully complete this activity and obtain your credit certificate:
Course Content:
• Watch the recording.
• Complete the post-test and receive a passing rate of 70%.
• Click Evaluation to complete the final course evaluation (2-3 minutes).
• Follow instructions at the end of the course regarding how to retrieve a certificate.
• If you have any questions or you do not receive your certificate, please email [email protected]
• 30 days following your completion of this activity, you will receive a survey (2 questions) to ask about changes in your practice.
Learning Objectives:
At the conclusion of this session, participants will
• Review and examine the latest clinical data investigating the use of psychedelics to treat various substance use disorders, including the limitations of the data.
• Describe the subjective experiences of psychedelics as reported by clinical trial participants.
• Determine the rationale for studying psychedelic use in the context of psychotherapy.
• Examine the risks and benefits of utilization of inpatient therapy. Provide tools to communicate with patients about risks and informed consent.
Additional Details Will Be Posted as Soon as Information is Available.
